AVIBELA: How JPA Health Launched a Global Online Hub for a Low-Cost IUD
JPA Health worked with Medicines360, a nonprofit pharmaceutical organization, to develop the global product website for AVIBELATM, a low-cost hormonal IUD contraceptive.
The Impact
1,623 users
and 2300+
page views
the first month
after launch
Resource
downloads
in multiple
languages
45% of users
came from key markets
in Kenya, Panama,
Nigeria,
and China
The Challenge
Women lack information about long-acting reversible contraceptives in low-income areas in Africa, South and Southeast Asia, Central America, and the Caribbean.
Our Approach
To close the IUD information gap, we developed a web portal tailored for and strategically marketed to reach women in these key markets. The portal was informed by research among patients in our key target markets and designed to meet their stated need for practical and solution-oriented information to close the access gap.
The Solution
In less than 6 weeks, JPA Health developed and launched Avibela.com. The site effectively explains IUDs, highlights AVIBELA product characteristics, describes how and where to get the product, and even offers training resources for HCPs. This website exceeded anticipated interest soon after launch and continues to drive demand as Medicines360 continues its work expanding global access.
